Paper22474009
Emerging therapeutics targeting mRNA translation.
Malina A and 2 others. Cold Spring Harb Perspect Biol, 2012. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Emerging therapeutics targeting mRNA translation. Papers, record 22474009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22474009
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Protein Biosynthesis | Major topic |
| RNA, Messenger | Major topic |
| Eukaryotic Initiation Factor-4F | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Canadian Institutes of Health Research | Canada | PubMed |
Source PubMed
References133
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17923237 | Synthesis of anti-reverse cap analogs (ARCAs) and their applications in mRNA translation and stability. | Methods Enzymol | 2007 | https://conductscience.org/library/papers/17923237 | PubMed |
| 2 | 632288 | The effect of "cap" analogs on reovirus mRNA binding to wheat germ ribosomes. Evidence for enhancement of ribosomal binding via a preferred cap conformation. | J Biol Chem | 1978 | https://conductscience.org/library/papers/632288 | PubMed |
| 3 | 17889643 | Non-oncogene addiction and the stress phenotype of cancer cells. | Cell | 2007 | https://conductscience.org/library/papers/17889643 | PubMed |
| 4 | 17806093 | Enantioselective synthesis of the complex rocaglate (-)-silvestrol. | Angew Chem Int Ed Engl | 2007 | https://conductscience.org/library/papers/17806093 | PubMed |
| 5 | 18551192 | Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18551192 | PubMed |
| 6 | 19726085 | Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells. | Leuk Res | 2010 | https://conductscience.org/library/papers/19726085 | PubMed |
| 7 | 20068177 | Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2. | Cancer Res | 2010 | https://conductscience.org/library/papers/20068177 | PubMed |
| 8 | 18664580 | mTORC1 promotes survival through translational control of Mcl-1. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18664580 | PubMed |
| 9 | 21233335 | Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases. | Cancer Res | 2011 | https://conductscience.org/library/papers/21233335 | PubMed |
| 10 | 2348862 | Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. | Nature | 1990 | https://conductscience.org/library/papers/2348862 | PubMed |
| 11 | 19412536 | Altering chemosensitivity by modulating translation elongation. | PLoS One | 2009 | https://conductscience.org/library/papers/19412536 | PubMed |
| 12 | 21946274 | A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer. | Nat Chem Biol | 2011 | https://conductscience.org/library/papers/21946274 | PubMed |
| 13 | 9200613 | Cocrystal structure of the messenger RNA 5' cap-binding protein (eIF4E) bound to 7-methyl-GDP. | Cell | 1997 | https://conductscience.org/library/papers/9200613 | PubMed |
| 14 | 11426655 | The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. | Oncogene | 2000 | https://conductscience.org/library/papers/11426655 | PubMed |
| 15 | 21191102 | Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21191102 | PubMed |
| 16 | 8387896 | Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. | Cell | 1993 | https://conductscience.org/library/papers/8387896 | PubMed |
| 17 | 21228037 | Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy. | Haematologica | 2011 | https://conductscience.org/library/papers/21228037 | PubMed |
| 18 | 8603359 | Upregulated expression of the genes encoding translation initiation factors eIF-4E and eIF-2alpha in transformed cells. | Cancer Lett | 1996 | https://conductscience.org/library/papers/8603359 | PubMed |
| 19 | 20687060 | Biomimetic photocycloaddition of 3-hydroxyflavones: synthesis and evaluation of rocaglate derivatives as inhibitors of eukaryotic translation. | Angew Chem Int Ed Engl | 2010 | https://conductscience.org/library/papers/20687060 | PubMed |
| 20 | 19417157 | Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A. | Mol Cancer Ther | 2009 | https://conductscience.org/library/papers/19417157 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41708776 | RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/41708776 | PubMed |
| 39941899 | Distinct NF-kB Regulation Favors a Synergic Action of Pevonedistat and Laduviglusib in B-Chronic Lymphocytic Leukemia Cells Ex Vivo. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941899 | PubMed |
| 35495621 | Function and Therapeutic Implications of tRNA Derived Small RNAs. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/35495621 | PubMed |
| 35412250 | Speed Microscopy: High-Speed Single Molecule Tracking and Mapping of Nucleocytoplasmic Transport. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35412250 | PubMed |
| 34541613 | Control of the eIF4E activity: structural insights and pharmacological implications. | Cell Mol Life Sci | 2021 | https://conductscience.org/library/papers/34541613 | PubMed |
| 33544578 | The Recurring Roles of Chlorine in Synthetic and Biological Studies of the Lissoclimides. | Acc Chem Res | 2021 | https://conductscience.org/library/papers/33544578 | PubMed |
| 33299354 | Effective Inhibition of MYC-Amplified Group 3 Medulloblastoma Through Targeting EIF4A1. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33299354 | PubMed |
| 33148274 | Eukaryotic translation initiation factors as promising targets in cancer therapy. | Cell Commun Signal | 2020 | https://conductscience.org/library/papers/33148274 | PubMed |
| 32637352 | Salubrinal in Combination With 4E1RCat Synergistically Impairs Melanoma Development by Disrupting the Protein Synthetic Machinery. | Front Oncol | 2020 | https://conductscience.org/library/papers/32637352 | PubMed |
| 32404434 | Host-Directed Antiviral Therapy. | Clin Microbiol Rev | 2020 | https://conductscience.org/library/papers/32404434 | PubMed |
| 31481479 | DUBbing Down Translation: The Functional Interaction of Deubiquitinases with the Translational Machinery. | Mol Cancer Ther | 2019 | https://conductscience.org/library/papers/31481479 | PubMed |
| 31235692 | Role of network-mediated stochasticity in mammalian drug resistance. | Nat Commun | 2019 | https://conductscience.org/library/papers/31235692 | PubMed |
| 30595437 | The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA. | Mol Cell | 2019 | https://conductscience.org/library/papers/30595437 | PubMed |
| 30532767 | The Role of the Eukaryotic Translation Initiation Factor 4E (eIF4E) in Neuropsychiatric Disorders. | Front Genet | 2018 | https://conductscience.org/library/papers/30532767 | PubMed |
| 30181176 | Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia. | Blood | 2018 | https://conductscience.org/library/papers/30181176 | PubMed |
| 30042762 | Advancements in Host-Based Interventions for Influenza Treatment. | Front Immunol | 2018 | https://conductscience.org/library/papers/30042762 | PubMed |
| 29440069 | Therapeutic Opportunities in Eukaryotic Translation. | Cold Spring Harb Perspect Biol | 2018 | https://conductscience.org/library/papers/29440069 | PubMed |
| 29064494 | Synthesis facilitates an understanding of the structural basis for translation inhibition by the lissoclimides. | Nat Chem | 2017 | https://conductscience.org/library/papers/29064494 | PubMed |
| 28322844 | A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis. | Eur J Pharmacol | 2017 | https://conductscience.org/library/papers/28322844 | PubMed |
| 28087713 | Functional genomics reveals that tumors with activating phosphoinositide 3-kinase mutations are dependent on accelerated protein turnover. | Genes Dev | 2016 | https://conductscience.org/library/papers/28087713 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EIF4G1 | 1981 | PubTator's text mining | https://conductscience.org/library/genes/1981 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22474009
GET https://conductscience.org/api/papers/v1/22474009/references?page=2